This HTML5 document contains 193 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n8http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q34580726
rdf:type
wikibase:Item
schema:description
מאמר מדעי 2007年论文 bài báo khoa học article scientific artigo científico (publicado na 2007) articol științific 2007年论文 2007 թուականի Յունիսին հրատարակուած գիտական յօդուած 2007 nî lūn-bûn articolo scientifico 2007年论文 vitenskapelig artikkel научна статия سائنسی مضمون bilimsel makale ২০০৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2007 թվականի հունիսին հրատարակված գիտական հոդված artikull shkencor мақолаи илмӣ научни чланак ശാസ്ത്രപ്രബന്ധം​ 2007年の論文 article científic 2007年論文 vitskapeleg artikkel artigo científico مقالة علمية 2007年論文 vetenskaplig artikel наукова стаття, опублікована в червні 2007 vedecký článok wissenschaftlicher Artikel vědecký článek tieteellinen artikkeli scientific article 2007年论文 videnskabelig artikel (udgivet 2007) مقالهٔ علمی wetenschappelijk artikel tudományos cikk επιστημονικό άρθρο научная статья artykuł naukowy мақолаи илмӣ scienca artikolo 2007年论文 artículu científicu espublizáu en 2007 artikulong pang-agham 2007년 논문 2007年論文 სამეცნიერო სტატია article scientifique (publié 2007) 2007年论文 2007年論文 научни чланак บทความทางวิทยาศาสตร์ artigo científico (publicado na 2007) 2007年論文 naučni članak teaduslik artikkel artículo científico publicado en 2007 mokslinis straipsnis
p:P577
wds:Q34580726-598E19CA-DD72-4818-A99D-44C3182DF17D
wdt:P577
2007-06-01T00:00:00Z
p:P407
wds:Q34580726-B834A396-A183-4F10-B5BD-E34E8555D46D
wdt:P407
wd:Q1860
p:P2860
wds:Q34580726-6EA39E45-74CD-42D6-A9B1-9E5270855B88 wds:Q34580726-68800D81-12B1-41E6-AD17-7EF5628500C6 wds:Q34580726-68801C04-5818-4EBE-BD14-62E649D7D687 wds:Q34580726-69778899-076D-4D98-896B-83DE33D3679F wds:Q34580726-807176F3-52E4-436D-BBD6-DF96C00E42D6 wds:Q34580726-3A93ACD6-F405-49BB-900C-0BEFCC488A2E wds:Q34580726-3C7939F0-5286-4BBD-9500-10FFFC695D65 wds:Q34580726-247DCBBD-8ED6-46A9-AE1D-FB4B376085CE wds:Q34580726-5451307A-4C1E-45ED-9C30-DED6A5681F89 wds:Q34580726-61336E51-F3C8-4062-8106-E6A74D78364E wds:Q34580726-E065D2A9-5170-4431-8796-C9CFCF1CC085 wds:Q34580726-B024BC43-68BD-4EEB-99B4-0B494C819DF2 wds:Q34580726-B7011FB0-477A-4DD8-97C1-51F7168019F1 wds:Q34580726-A9DA542B-B73F-47AF-BF24-B1C0E55E778E wds:Q34580726-AAB09D72-BA4F-4099-93E1-CFE9FDBF07E7 wds:Q34580726-BDA1213A-D238-435D-81FB-52C05F2E2F69 wds:Q34580726-BF0E2FD8-D69D-43AB-B2E1-C565D7D82213 wds:Q34580726-06DC39E4-62F6-40D1-A001-AEB294E3B0ED wds:Q34580726-110B0946-4989-4E68-B7DF-2ACAF052B437 wds:Q34580726-1118BA07-552E-49F3-9DF5-5C7E925168D5
wdt:P2860
wd:Q40227526 wd:Q36610447 wd:Q44574224 wd:Q64112091 wd:Q28236008 wd:Q39683911 wd:Q29616213 wd:Q42038224 wd:Q29618731 wd:Q35073297 wd:Q52602533 wd:Q36891915 wd:Q36238689 wd:Q35999045 wd:Q40788937 wd:Q34068782 wd:Q45552005 wd:Q81499715 wd:Q29617514 wd:Q73414358
p:P2093
wds:Q34580726-996FCEEA-0381-4FA4-B3BB-A28185E6DA7E wds:Q34580726-A189F409-7400-48AC-845A-B0CB0377F99A wds:Q34580726-C6296AEA-2E03-40CB-9094-35C5D29DF5B0 wds:Q34580726-C859F09D-170C-42D2-B73E-91FE79AAEF72 wds:Q34580726-D520F7C7-A6CE-4FBC-A6DF-CF89424AD4B8 wds:Q34580726-F7337016-586B-4712-81BB-0C6FF16AF4CC wds:Q34580726-2749F51B-F49B-4B3D-8822-305A1ACDBE3F wds:Q34580726-52159C79-DA6D-4889-B481-9BD6D3493677 wds:Q34580726-530D03EC-1CB3-4280-A636-3A8F4739914F wds:Q34580726-447237E1-6BD1-41D9-94CF-E79AD11A4552 wds:Q34580726-449120AF-8300-4720-BD25-1DF5115D95C2 wds:Q34580726-5C562975-9C08-49FE-8DD8-EC2812499520 wds:Q34580726-79197D8F-F0D5-43E7-A6D7-097B48B39A91 wds:Q34580726-6DE3ED51-92A1-426E-B667-68E250F8B65F wds:Q34580726-8510A28D-6439-45A8-8C84-EB4DA45F5745 wds:Q34580726-90A23A98-5534-4B0B-9815-C2690EC60C32 wds:Q34580726-013AACAB-FBE4-4751-ADDC-5D17B105395C
wdt:P2093
Diane M Harper Newton S de Carvalho Henry C Kitchener David Jenkins Matti O Lehtinen Genara Am Limson Unnop Jaisamrarn HPV PATRICIA study group Bart Spiessens Song-Nan Chow Gary Dubin Xavier Castellsague Susan L Wieting Pascal Peeters James A Hedrick Paulo Naud Marc Dionne
rdfs:label
Eficacia de una vacuna de partículas similares al virus L1 bivalente con adyuvante profiláctico contra la infección por virus del papiloma humano tipos 16 y 18 en mujeres jóvenes: un análisis intermedio de un ensayo controlado aleatorizado. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial
skos:prefLabel
Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial Eficacia de una vacuna de partículas similares al virus L1 bivalente con adyuvante profiláctico contra la infección por virus del papiloma humano tipos 16 y 18 en mujeres jóvenes: un análisis intermedio de un ensayo controlado aleatorizado. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial
schema:name
Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial Eficacia de una vacuna de partículas similares al virus L1 bivalente con adyuvante profiláctico contra la infección por virus del papiloma humano tipos 16 y 18 en mujeres jóvenes: un análisis intermedio de un ensayo controlado aleatorizado. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial
p:P50
wds:Q34580726-16E5B810-4A54-4A5B-8B12-C7F7F10337E4 wds:Q34580726-3E0064CF-6708-4984-A8CC-F7F344C0469E wds:Q34580726-84E1A48B-5976-4ED2-8CCC-CFF61C5787D0 wds:Q34580726-993CFC6D-AC96-43B0-922A-2D36D34BA786 wds:Q34580726-7AFC103A-EDEB-46C4-93F6-1725F8AB6E68 wds:Q34580726-C5406068-E047-4095-94FF-26D800699B08 wds:Q34580726-B62E24EE-2AB7-42C7-9017-C0172166896A wds:Q34580726-D5AA59CF-8337-40C0-88EB-F8363E0B7877
wdt:P50
wd:Q55186651 wd:Q56376448 wd:Q87723651 wd:Q115787230 wd:Q58664238 wd:Q63372147 wd:Q88733900 wd:Q47710870
p:P1476
wds:Q34580726-863171AC-F410-47BD-BD52-858EEEBC9DE7
wdt:P1476
Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial
p:P304
wds:Q34580726-C0984E0D-67C9-48AA-83B7-E9839197FD5B
wdt:P304
2161-2170
p:P31
wds:Q34580726-1664A53A-0BC5-4763-9766-BB2898BFA81A
wdt:P31
wd:Q13442814
p:P921
wds:Q34580726-8E7A5C2F-1768-4643-9A68-CB03A3DAF73A wds:Q34580726-99443EC7-2C37-432F-94AA-CCF719FBA734
wdt:P921
wd:Q42824827 wd:Q134808
p:P698
wds:Q34580726-6B06721B-EBDE-4D2B-AD2B-D24C12AFC859
wdtn:P698
n10:17602732
wdt:P698
17602732
p:P1433
wds:Q34580726-07E3A490-4EF8-47A3-AA67-44AFCBC689A7
wdt:P1433
wd:Q939416
p:P433
wds:Q34580726-AB79CE22-AA57-4DED-AAA2-DE02A499ACB2
p:P478
wds:Q34580726-3092B596-91D7-42F1-80C2-A3D0B0F0938A
wdt:P433
9580
wdt:P478
369
p:P356
wds:Q34580726-B8A3D7DF-ADB1-44A0-B6F5-99E69438F1FD
wdtn:P356
n8:S0140-6736(07)60946-5
wdt:P356
10.1016/S0140-6736(07)60946-5
p:P5875
wds:Q34580726-EDF936B0-42CF-4FD2-8F01-487F071373DC
wdt:P5875
6234359